"Dose Response to Ipratropium as a Nebulized Solution in Patients with Chronic Obstructive Pulmonary Disease." American Review of Respiratory Disease, 140(4), p. 1174
No takes yet. Share an insight, caveat, or question.
Mordecai N. Dunst (1989) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: